The Cell & Gene Therapy Congress 2026 brings together leading clinicians, researchers, industry partners, and policymakers to explore the latest advances shaping the future of regenerative medicine.
The programme focuses on translating scientific innovation into real-world clinical applications — from emerging therapies and manufacturing to regulatory, ethical, and safety considerations — with a dedicated emphasis on mesenchymal stem/stromal cell (MSC) developments.
The event will be officiated by Tan Sri Dato’ Dr. Abu Bakar Suleiman, Chancellor of the International Medical University (IMU) and Clinical Advisor to the Minister of Health Malaysia.